Evidence map›Paper›PMID 26099726›Full record

ArticleTumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine2015

Fuzzy clustering demonstrates that codon 72 SNP rs1042522 of TP53 gene associated with HNSCC but not with prognoses.

Ugo Borges Pinheiro, Carlos Alberto de Carvalho Fraga, Danilo Cangussu Mendes, Lucyana Conceição Farias, Cláudio Marcelo Cardoso, Christine Mendes Silveira, Marcos Flávio Silveira Vasconcelos D'Angelo, Kimberly Marie Jones, Sérgio Henrique Souza Santos, Alfredo Maurício Batista de Paula and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.1field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. TheBiomedicines · 2023
    Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Ugo Borges PinheiroDepartment of Dentistry, Universidade Estadual de Montes Claros, Montes Claros, Brazil.
Carlos Alberto de Carvalho FragaDepartment of Dentistry, Universidade Estadual de Montes Claros, Montes Claros, Brazil.
Danilo Cangussu MendesDepartment of Dentistry, Universidade Estadual de Montes Claros, Montes Claros, Brazil.
Lucyana Conceição FariasDepartment of Dentistry, Universidade Estadual de Montes Claros, Montes Claros, Brazil.
Cláudio Marcelo CardosoDepartment of Medicine and Department of Computer Science, Universidade Estadual de Montes Claros, Montes Claros, Brazil.
Christine Mendes SilveiraDepartment of Medicine and Department of Computer Science, Universidade Estadual de Montes Claros, Montes Claros, Brazil.
Marcos Flávio Silveira Vasconcelos D'AngeloUniversidade Estadual de Montes Claros, Montes Claros, Brazil.
Kimberly Marie JonesCenter for Research, The Educative Association of Brazil, Montes Claros, Brazil.
Sérgio Henrique Souza SantosDepartment Pharmacology, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
Alfredo Maurício Batista de PaulaDepartment of Dentistry, Universidade Estadual de Montes Claros, Montes Claros, Brazil.
André Luiz Sena GuimarãesDepartment of Dentistry, Universidade Estadual de Montes Claros, Montes Claros, Brazil. andreluizguimaraes@gmail.com.
Universidade Estadual de Montes Claros · BRUniversidade Federal de Minas Gerais · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It is estimated that 7.6 million people will die as a consequence of head and neck squamous cell carcinoma (HNSCC). Genetic predisposition has emerged as an important risk factor in the development and prognosis of HNSCC. Considering this, the aim of the current study is to assess whether codon 72 SNP of the TP53 gene (rs1042522) is associated with an increased odds ratio of developing HNSCC or with a worse prognosis in patients with HNSCC. Analysis of the rs1042522 in HNSCC patients and in control individuals. Differences between the case and control groups were determined using chi-squared tests. Multivariate analysis was performed to evaluate the odds ratio of HNSCC. Fussy C Means Clustering was to cluster HNSCC patients for survival analyses. Time of survival was calculated using the Kaplan-Meier estimator and comparing this to the log rank test. Statistical significance was set at p < 0.05. A total of 71.4 % of the Arg/Arg genotype were from HNSCC patients, while only 28.6 % of Arg/Arg genotype were found in the control group. Logistic regression demonstrated that the Arg/Arg genotype, smoking, and alcohol consumption increase the odds ratio of HNSCC. No association between TP53 codon 72 polymorphism and P53 expression. No association between rs1042522 and survival or prognoses was observed. This study identified that individuals carrying the arginine allele at rs1042522 have an increased odds ratio of HNSCC. However, no association between codon 72 SNP of the TP53 gene and HNSCC prognosis or P53 expression was observed.

Indexed as

Genetic Predisposition to DiseasePrognosisAdultAgedAged, 80 and overCarcinoma, Squamous CellCodonFemaleGene Expression Regulation, NeoplasticGene FrequencyGenetic Association StudiesGenotypeHead and Neck NeoplasmsHumansKaplan-Meier EstimateMaleCodonTP53 protein, humanTumor Suppressor Protein p53Oral cancerp53SurvivalTumor suppressor gene

Identifiers

PMID26099726
OpenAlexW844678728

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.